@strmltrofomonas @LondonUmejiaku Wake Forest is recruiting externally for ID PGY2 this year!

@ConanMacDougall When there’s a good reason to use amox/clav instead of amox alone but I’m uncomfortable with sacrificing the amox dose, I will add a middle dose of amox alone. Maybe I’m treating myself but this conversation makes me feel validated.

@UKPharmRes @hpcurry23 Congrats to Nicole Slain and @hpcurry23. @UKPharmRes and Katie Wallace are getting two ID pharmacy rockstars in the making. ID ties between UK and @WakeForestRxRes keep growing. @ashlogan518

Excited to announce the Wake Forest Baptist PGY2 Infectious Diseases Pharmacy Residency has matched with Courtney Jackson. Looking forward to a great year together! @mcrxresidency @WakeForestRxRes

@ECUHealthRxRes @AFieldPharmD Had the pleasure of getting to know Sari during interviews. So happy to see her match at UVA and with RPD Heather Cox Hall, my former PGY2 ID resident. @UVARxResidency @HCoxIDPharmD

@lynnwardlow @blandman19 @s_travis_king Likewise, so happy for Natt!

For pts with ESRD on intermittent HD, would you ever consider dosing ceftriaxone TIW after HD?

@blandman19 @SERGE_45_ABX @mlbrownrx @reagan_kiger @BBookstaver_USC Appreciate the recognition of our paper by these @SERGE_45_ABX authors. Shout out to K. Wallace at UK, @lizzofloxacin, and all the @WakeForestRxRes residents who worked hard to perform our study.

The Wake Forest Baptist PGY2 Infectious Diseases Pharmacy Residency is holding 2 info sessions. If interested, go to our website to sign up. #SIDPharm #TwitteRx

@nbennett04 Not bad… I tend to think ertapenem is to carbapenems as ceftriaxone is to cephalosporins - owing to its protein binding, once daily dosing, and lack of Pseudomonas activity.

@ConanMacDougall @dralicehan @julie_justo @Cortes_Penfield @EB_Hirsch @OncIDPharmd @mmPharmD @DosingMatters @PharmerMeg @ErinMcCreary It’s a shame the XR of Augmentin XR only applies to the amoxicillin part. A PTA study is definitely in order here, ideally with weight included as a variable.

@julie_justo @ConanMacDougall @Cortes_Penfield @EB_Hirsch @OncIDPharmd @mmPharmD @DosingMatters @PharmerMeg @ErinMcCreary Personally I prefer more frequent dosing of amox/clav owing to the short half-life of clav, ie increasing the dose doesn’t buy much exposure. Going old school here - but we used to dose Timentin up to Q4h. That’s 100mg clav Q4h. Biggest concern is probably DILI.

Patient presents with infection and has historical culture positive for ESBL producer. Is ESBL targeted antibiotic always necessary? Check out our online tool to predict risk for ESBL subsequent infection:

@BBookstaver_USC @PHUofSCPharmRes @UofSCPharm @bamardis @ASHPOfficial Wondering if/when pharmacy students are introduced to all these possible career paths. As evidenced by recent match experience, interest in some is very low. Investigational Drugs and Research for instance

@ABsteward @strmltrofomonas 100% agree. This brings back memories of one of my residency projects.

@pharmd_jc Stay tuned! An online calculator to predict risk for subsequent infection with ESBL is coming soon. #IDTwitter #TwitteRx

@OncIDPharmd @davidvanduin @The_Real_Shrops @IdVilchez @IDstewardship @DrNeilStone @NateWarnerMD @ClancyNeil @LDanielsPharmD Maybe TEM-43? But if aztreonam susceptible, consider retesting susceptibilities (query bad batch of plates). Agree with carbapenem pending more info.

@BBookstaver_USC @rcmccorm @WakeForestRxRes @UofSCPharm Great things await! The pipeline between @UofSCPharm and @WakeForestRxRes is alive and well!

@andrewhaynes @IDPharmacometrx @KaylaAntosz @BBookstaver_USC @jc_pharmacist I agree with you @andrewhaynes. I’m not convinced CSF penetration of abx is applicable to epidural space infections. Need more research on differentiating epidural abscess from infections involving meninges or brain.